BackTheratechnologies Overview

Theratechnologies Net Income

Latest net income for THTX: $-9.2M, below the Healthcare sector average of $16B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$4.46M
552.21% YoY

As of May 2025

Annual Net Income (TTM)

-$9.16M
31.74% YoY

Trailing 12 months ending May 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Theratechnologies (THTX) FAQ

Theratechnologies (THTX) currently reports a net income of $-9.2M as of May 2025. That compares with $-7M in the prior-year period — down 31.7% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Theratechnologies's net income history and peer comparisons.

Theratechnologies's net income decreased from $-7M to $-9.2M — a 31.7% year-over-year decrease (period ending May 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Theratechnologies's net income of $-9.2M is lower than the Healthcare sector average of $16B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Theratechnologies reported $-9.2M in net income as of May 2025. That compares with $-7M in the prior-year period — down 31.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-9.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Theratechnologies, and consider following THTX for alerts when major investors trade the stock.